AP
AMED

Advisor Partners’s Amedisys AMED Stock Holding History

Advisor Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,642
Closed -$283K – 838
2022
Q1 		$283K Buy
1,642
+316
+24% +$47.2K 0.02% 693
2021
Q4 		$215K Buy
+1,326
New +$213K 0.01% 796
2021
Q3 		– Sell
-1,064
Closed -$261K – 808
2021
Q2 		$261K Sell
1,064
-25
-2% -$6.56K 0.02% 698
2021
Q1 		$288K Buy
1,089
+43
+4% +$12.1K 0.02% 645
2020
Q4 		$307K Sell
1,046
-30
-3% -$7.69K 0.02% 586
2020
Q3 		$254K Buy
1,076
+19
+2% +$4.32K 0.02% 571
2020
Q2 		$210K Buy
+1,057
New +$197K 0.02% 616

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Advisor Partners's AMED Position: Q2 2022 in Review

Advisor Partners sold out of Amedisys (AMED) in Q2 2022, closing a stake of 1,642 shares — an estimated $283K sold.

Advisor Partners first reported a position in AMED in Q2 2020 and held it in 7 quarters. The position peaked at $307K in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Advisor Partners reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Advisor Partners sold 1,642 Amedisys shares in Q2 2022, an estimated $283K.
  • Advisor Partners first reported a position in Amedisys in Q2 2020 and held it in 7 quarters.
  • Advisor Partners's Amedisys position peaked at $307K in Q4 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.